scorecard
  1. Home
  2. Science
  3. Health
  4. news
  5. 3 lingering vaccine questions we still have

3 lingering vaccine questions we still have

Lydia Ramsey Pflanzer   

3 lingering vaccine questions we still have

Hello,

Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:

If you're new to this newsletter, sign up here. Comments, tips? Email me at lramsey@insider.com or tweet @lydiaramsey125. Let's get to it...


First, I wanted to let you know that we're now accepting nominations for our annual list of 30 leaders under 40 transforming healthcare.

This will be our fifth (!) list, and I'm excited to see how it shapes up (here's last year's in case you missed it). We're looking for nominees from all parts of healthcare - from up-and-comers within large companies, to entrepreneurs, to scientists and clinicians.

Think you know someone who'd be great? Submit their name here by June 30.



3 lingering questions about COVID-19 vaccines will shape the pandemic's trajectory into 2022 and beyond

Here are the key questions>>


A fight over patents in the psychedelics industry is just getting started, and it stands to shape the future of a $100 billion market

Find out more about what's at stake>>



Coronavirus variants now have simple, easy-to-remember WHO names, which helps avoid the 'stigma' of referring to them by a specific country

Find out more>>


More stories we're reading:


- Lydia

READ MORE ARTICLES ON



Popular Right Now



Advertisement